Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts

Experimental Neurology

Volumn 149, Issue 1, 1998, Pages 230-236

  Sautter, J ^a   Tseng, J L ^b   Braguglia, D ^b   Aebischer, P ^b   Spenger, C ^a   Seiler, R W ^a   Widmer, H R ^a   Zurn, A D ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Dopamine; Neurotrophic factor; Rat; Rotation behavior; Transplant; Tyrosine hydroxylase

Indexed keywords

NEUROTROPHIC FACTOR;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENCAPSULATION; FETUS; GLIA CELL; GRAFT SURVIVAL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031936437     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6718     Document Type: Article

References (32)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247.
2. Aebischer P., Tresco P. A., Winn S. R., Greene L. A., Jaeger C. B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:1991;269-275.
3. Aebischer P., Tan S. A., Déglon N., Heyd B., Zurn A. D., Baetge E., Sagot Y., Kato A. C. Encapsulation of neurotrophic factor-releasing cells for the treatment of neurodegenerative diseases. Restor. Neurol. Neurosci. 8:1995;65-66.
4. Aebischer P., Schluep M., Déglon N., Joseph J. M., Hirt L., Heyd B., Goddard M., Hammang J. P., Zurn A. D., Kato A. C., Regli F., Baetge E. E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amytrophic lateral sclerosis patients. Nature Med. 2:1996;696-699.
5. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
6. Choi-Lindberg D. L., Lin Q., Chang Y.-N., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
7. Dunnet S. B., Björklund A., Stenevi U., Iversen S. D. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 229:1981;209-217.
8. Gash D. M., Zhang Z. M., Ovadia A., Cass W. A., Yi A., Simmermann L., Russel D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;6571.
9. Hammang J. P., Emerich D. F., Winn S. R., Lee A., Lindner M. D., Gentile F. T., Doherty E. J., Kordower J. H., Baetge E. E. Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases. Cell Transplant. 4:1995;27-28.
10. Haque N. S. K., Hlavin M.-L., Fawcett J. W., Dunnett S. B. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res. 712:1996;45-52.
11. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopoulos G. D., Squinto S. P., Lindsay R. M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1993;230-232.
12. Hynes M. A., Poulsen K., Armanini M., Berkemeier L., Phillips H., Rosenthal A. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37:1994;144-154.
13. Johansson M., Friedemann M., Hoffer B., Strömberg I. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134:1995;25-34.
14. Kordower J. H., Mufson E. J., Granholm A.-C., Hoffer B., Friden P. M. Delivery of trophic factors to the primate brain. Exp. Neurol. 124:1993;21-30.
15. Lin L.-F., Doherty J., Lile J., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
16. Mandel R. J., Brundin P., Björklund A. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur. J. Neurosci. 2:1990;888-894.
17. Mayer E., Dunnett S. B., Pelliteri R., Fawcett J. W. Basic fibrobalst growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. I. Effectsin vitro. Neuroscience. 56:1993;379-388.
18. Mayer E., Fawcett J. W., Dunnett S. B. Basic fibrobalst growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. II. Effects on nigral transplantsin vivo. Neuroscience. 56:1993;389-398.
19. Meyer M., Widmer H. R., Evtouchenko L., Guzman R., Seiler R. W., Zimmer J., Spenger C. Transplantation of fresh cell suspensions versus cultured tissue of fetal rat mesencephalon to 6-hydroxydopamine lesioned rats. Soc. Neurosci. Abstr. 22:1996;1492.
20. Olanow C. W., Kordower J. H., Freeman T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. TINS. 19:1996;83-117.
21. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience. 75:1996;979-985.
22. Sauer H., Fischer W., Nikkhah G., Wiegand S. J., Brundin P., Lindsay R. M., Björklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626:1993;37-44.
23. Sauer H. J., Rosenblad C., Björklund A. GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine-lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
24. Sinclair S. R., Svendsen C. N., Torres E. M., Martin D., Fawcett J. W., Dunnett S. B. GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport. 7:1996;2547-2552.
25. Spenger C., Studer L., Evtouchenko L., Egli M., Burgunder M., Markwalder R., Seiler R. W. Long-term survival of dopaminergic neurons in free-floating roller tube cultures of human fetal ventral mesencephalon. J. Neurosci. Methods. 54:1994;63-73.
26. Spenger C., Hyman C., Studer L., Egli M., Evtouchenko L., Jackson C., Dahl-Jorgensen A., Lindsay R. M., Seiler R. W. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in culture of human fetal ventral mesencephalon. Exp. Neurol. 133:1995;50-63.
27. Spenger C., Haque N. S. K., Studer L., Evtouchenko L., Wagner B., Bühler B., Lendahl U., Dunnett S. B., Seiler R. W. Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons. Exp. Brain Res. 112:1996;47-57.
28. Takayama H., Ray J., Raymon H. K., Baird A., Hogg J., Fisher L. J., Gage F. H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1:1995;53-58.
29. Tomac A., Lindqvist E., Lin L. F. H., Ögren S. O., Young D., Hoffer B. J., Olsen L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
30. Tseng J. L., Baetge E. E., Zurn A. D., Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. 17:1997;325-333.
31. Wang Y., Tien L. T., Lapchak P. A., Hoffer B. J. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Cell Tissue Res. 286:1996;225-233.
32. Yurek D. M., Lu W. L., Hipkens S., Wiegand S. J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:1996;105-118.